Picture of Benchmark Holdings logo

BMK Benchmark Holdings News Story

gb flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

REG - Benchmark Hlgs PLC - Notice of Q3 Results

For best results when printing this announcement, please click on link below:

RNS Number : 3496U  Benchmark Holdings PLC  01 August 2022

1 August 2022


Benchmark Holdings plc


("Benchmark" or the "Company")


Notice of Q3 Results


Webcast for analysts and institutional investors

Equity Development webcast for retail investors


Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition,
and genetics business, will announce its Q3 results for the three month period
ended 30 June 2022, on Thursday 25(th) August 2022.


Webcast for analysts and institutional investors at 9am UK time


Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a webcast for analysts and institutional investors on that
day at 09:00am UK time. To register your interest, please
contact benchmark@mhpc.com (mailto:benchmark@mhpc.com) .


Equity Development webcast for retail investors at 12:00pm UK time


Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a separate webcast for retail investors and wealth managers
at 12.00pm UK time. The webcast is open to all existing and potential
shareholders. Questions can be submitted during the presentation which will be
addressed at the end.


To register please visit:




 For further information, please contact:
 Benchmark Holdings plc                           Tel:  020 3696 0630
 Trond Williksen, CEO
 Septima Maguire, CFO
 Ivonne Cantu, Investor Relations

 Numis (Broker and NOMAD)                         Tel:  020 7260 1000
 James Black, Freddie Barnfield, Duncan Monteith

 MHP Communications                               Tel:  020 3128 8990
 Katie Hunt, Reg Hoare, Charlie Protheroe         benchmark@mhpc.com

 Equity Development                               020 7065 2690

 Hannah Crowe


About Benchmark

Benchmark is a market leading aquaculture biotechnology company. Benchmark's
mission is to drive sustainability in aquaculture by delivering products and
solutions in genetics, advanced nutrition and health which improve yield,
growth and animal health and welfare.

Through a global footprint in 26 countries and a broad portfolio of products
and solutions, Benchmark addresses the major aquaculture species - salmon,
shrimp, sea bass and bream, and tilapia,  in all the aquaculture regions
around the world. Find out more at www.benchmarkplc.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)

Recent news on Benchmark Holdings

See all news